Choreo LLC Grows Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Choreo LLC increased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 11.9% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 6,026 shares of the company’s stock after purchasing an additional 643 shares during the period. Choreo LLC’s holdings in HCA Healthcare were worth $1,800,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently added to or reduced their stakes in the company. Legacy Investment Solutions LLC bought a new position in shares of HCA Healthcare during the third quarter worth $39,000. Capital Performance Advisors LLP bought a new position in shares of HCA Healthcare during the third quarter worth $41,000. Canoe Financial LP bought a new position in shares of HCA Healthcare during the third quarter worth $41,000. Northwest Investment Counselors LLC purchased a new stake in HCA Healthcare during the third quarter valued at $44,000. Finally, Friedenthal Financial purchased a new stake in HCA Healthcare during the third quarter valued at $50,000. 62.73% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of research firms recently issued reports on HCA. Oppenheimer upped their price target on shares of HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a research note on Monday, October 28th. Wells Fargo & Company downgraded shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and decreased their price target for the company from $400.00 to $320.00 in a research note on Monday, November 25th. Barclays reduced their target price on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a research note on Monday, January 27th. TD Cowen reduced their target price on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a research note on Monday, October 28th. Finally, Bank of America reduced their target price on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a research note on Monday, January 27th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, HCA Healthcare has an average rating of “Moderate Buy” and an average target price of $385.67.

HCA Healthcare Stock Down 0.8 %

Shares of HCA Healthcare stock opened at $321.95 on Friday. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14. The firm’s 50-day moving average is $313.85 and its two-hundred day moving average is $353.37. The stock has a market cap of $81.55 billion, a price-to-earnings ratio of 14.65, a PEG ratio of 1.13 and a beta of 1.64.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, beating analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period in the previous year, the company posted $5.90 EPS. As a group, research analysts expect that HCA Healthcare, Inc. will post 24.89 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be issued a $0.72 dividend. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.89%. The ex-dividend date of this dividend is Monday, March 17th. HCA Healthcare’s dividend payout ratio (DPR) is currently 12.02%.

Insider Activity at HCA Healthcare

In related news, insider Erol R. Akdamar sold 2,900 shares of the business’s stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the transaction, the insider now directly owns 6,843 shares in the company, valued at $2,415,579. The trade was a 29.76 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP Phillip G. Billington sold 3,897 shares of the business’s stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the completion of the transaction, the senior vice president now owns 52,702 shares of the company’s stock, valued at approximately $18,445,700. This represents a 6.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.70% of the stock is currently owned by insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.